Close Menu
Home › Helix, AdventHealth Partner on Genetic Screening Study

Helix, AdventHealth Partner on Genetic Screening Study

Apr 25, 2019
|
staff reporter

NEW YORK (GenomeWeb) – AdventHealth Orlando, a faith-based nonprofit health care system, and consumer genomics company Helix have partnered on a genetic screening study for familial hypercholesterolemia, a condition that causes high cholesterol and can lead to cardiovascular disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
10
Featured Webinar

Laboratory Validation of a Kit-Based Liquid Biopsy NGS Assay

This webinar will provide an overview of how a pathology laboratory validated a 77-gene next-generation sequencing-based liquid biopsy assay.

Oct
24
Featured Webinar

Designing, Decoding & Delivering on Genetic Testing for Inherited Disease at Versiti

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

What's Popular?

In Sequencing

  1. ACLA Urges FDA to Reconsider Recent PGx Enforcement Moves

  2. Curetis Reports 36 Percent Increase in H1 Revenues

  3. Fulgent Genetics Taps PWNHealth to Oversee New Tests Marketed to Consumers

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.